Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.42 USD | +5.19% | -19.77% | +61.36% |
Business Summary
Number of employees: 12
Managers
Managers | Title | Age | Since |
---|---|---|---|
Shu-Chih Chen
FOU | Founder | 62 | 08-11-30 |
Steven Quay
CEO | Chief Executive Officer | 73 | 08-11-30 |
Heather Rees
DFI | Director of Finance/CFO | - | 16-12-31 |
Arezoo Mirad
CTO | Chief Tech/Sci/R&D Officer | - | Dec. 03 |
Richard Graydon
CTO | Chief Tech/Sci/R&D Officer | - | 22-10-24 |
Delly Behen
ADM | Chief Administrative Officer | - | 13-12-31 |
Eric van Zanten
IRC | Investor Relations Contact | - | 22-12-06 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Quay
CEO | Chief Executive Officer | 73 | 08-11-30 |
Director/Board Member | 66 | 14-02-28 | |
H. Remmel
BRD | Director/Board Member | 72 | 12-01-31 |
Shu-Chih Chen
FOU | Founder | 62 | 08-11-30 |
Stephen Galli
BRD | Director/Board Member | 77 | 11-06-30 |
Jonathan Finn
BRD | Director/Board Member | 50 | Nov. 07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 126,624,110 | 125,230,652 ( 98.90 %) | 1,320,046 ( 1.042 %) | 98.90 % |
Stock B | 0 | 582 | 0 | 0 |
Company contact information
Atossa Therapeutics, Inc.
107 Spring Street
98104, Seattle
+206 588 0256
http://www.atossatherapeutics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+61.36% | 178M | |
-1.82% | 41.35B | |
+44.25% | 40.38B | |
+2.56% | 39.05B | |
-12.11% | 26.67B | |
+3.09% | 24.07B | |
-24.16% | 18.36B | |
+22.12% | 11.6B | |
-3.74% | 11.68B | |
+7.75% | 11.15B |
- Stock Market
- Equities
- ATOS Stock
- Company Atossa Therapeutics, Inc.